Last reviewed · How we verify
NCT06929793
Multiple Micronutrients Supplementation on Angiogenesis and Vasculogenesis Factors, and Fetal Biometry
NA trial testing Multiple Micronutrients in Angiogenesis in 200 participants. Participants enrolled and being followed up; not accepting new ones.
30 May 2025
Quick facts
| Lead sponsor | Dr Cipto Mangunkusumo General Hospital |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 March 2024 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Multiple Micronutrients
- Standard Antenatal Vitamin — full drug profile →
Conditions studied
- Angiogenesis — all drugs for Angiogenesis →
- Fetal Weight — all drugs for Fetal Weight →
- Pregnancy Related — all drugs for Pregnancy Related →
- Nutrient Element Deficiency — all drugs for Nutrient Element Deficiency →
Sponsor
Dr Cipto Mangunkusumo General Hospital
Who can join
Eligibility, female only, with Angiogenesis or Fetal Weight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multiple micronutrients play an important role during pregnancy, since the decidualization and implantation phases. It has an impact on placentation and remodeling of blood vessels. The optimal early pregnancy conditions accompanied by great angiogenesis and vasculogenesis factors will influence fetal growth. This study aims to determine the effect of maternal multiple micronutrient supplementation on angiogenesis factors, vasculogenesis factors, and fetal biometry. It is a clustered randomized controlled trial that aims to determine the impact of maternal micronutrient supplementation on PlGF levels, sFlt-1/PlGF ratio, mean pulsatility index of uterine artery, and fetal biometry (head circumference, femur length, and estimated fetal weight percentile). The target population for the study was all pregnant women who underwent antenatal check-ups at community health centers in DKI Jakarta.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06929793
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Angiogenesis
Currently open trials in the same condition.
- NCT04807166 — Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer · Phase 2 · active not recruiting
Other Dr Cipto Mangunkusumo General Hospital trials
Trials by the same sponsor.
- NCT07074548 — Effect of Hydroxytyrosol on NLR, MLR, and SOD in Hypertensive Pregnant Women · NA · completed
- NCT07141940 — Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients · NA · completed
- NCT07422116 — Non-Inferiority Test of Mixsafe® Compared to Neopuff® in Providing Respiratory Support to Neonates · NA · completed
- NCT07149272 — Lactate Kinetics Analysis Related to Low-Intensity Resistance Exercise · NA · completed
- NCT06035315 — The 1000 First Day of Life : Effect of Multi Micronutrients Supplementation on Pregnancy Outcomes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06929793 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Cipto Mangunkusumo General Hospital
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06929793.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing